Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Recommendations for COVID‐19 vaccination in people with rheumatic disease: Developed by the Singapore Chapter of Rheumatologists
Amelia Santosa, Chuanhui Xu, Thaschawee Arkachaisri, et al.
International Journal of Rheumatic Diseases (2021) Vol. 24, Iss. 6, pp. 746-757
Open Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

Administration of COVID-19 vaccines in immunocompromised patients
Manica Negahdaripour, Mojtaba Shafiekhani, Seyed Mohammad Iman Moezzi, et al.
International Immunopharmacology (2021) Vol. 99, pp. 108021-108021
Open Access | Times Cited: 72
A systematic review on mucocutaneous presentations after COVID‐19 vaccination and expert recommendations about vaccination of important immune‐mediated dermatologic disorders
Farnoosh Seirafianpour, Homa Pourriyahi, Milad Gholizadeh Mesgarha, et al.
Dermatologic Therapy (2022) Vol. 35, Iss. 6
Open Access | Times Cited: 52
Coronavirus Disease 2019 (COVID-19) and Immune-mediated Rheumatic Diseases. Recommendations of the Association of Rheumatologists of Russia
Е. Л. Насонов, А. М. Лила, Mazurov Vi, et al.
Rheumatology Science and Practice (2021) Vol. 59, Iss. 3, pp. 239-254
Open Access | Times Cited: 50
The risk assessment of uveitis after COVID‐19 diagnosis: A multicenter population‐based study
Ning‐Yi Hsia, Alan Y. Hsu, Yu‐Hsun Wang, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 10
Open Access | Times Cited: 12
Unveiling COVID‐19 treatment strategies for immunocompromised individuals: Therapeutic innovations and latest findings
Li‐Teh Liu, Jih‐Jin Tsai
International Journal of Rheumatic Diseases (2024) Vol. 27, Iss. 1
Open Access | Times Cited: 4
Risk factors associated with COVID‐19 pneumonia in Chinese patients with pre‐existing interstitial lung disease during the SARS‐CoV‐2 pandemic
Chi Shao, Yujie Shi, Ruxuan Chen, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 9
Open Access | Times Cited: 10
Post-mRNA vaccine flares in autoimmune inflammatory rheumatic diseases: Results from the COronavirus National Vaccine registry for ImmuNe diseases SINGapore (CONVIN-SING)
Margaret Ma, Amelia Santosa, Warren Fong, et al.
Journal of Autoimmunity (2022) Vol. 134, pp. 102959-102959
Open Access | Times Cited: 17
Safety of COVID-19 vaccines and disease flares after vaccines in children with rheumatic disease
Elif Arslanoğlu Aydın, Esra Bağlan, İlknur Bağrul, et al.
Postgraduate Medicine (2022) Vol. 134, Iss. 6, pp. 616-621
Closed Access | Times Cited: 14
Prevalence and factors associated with flares following COVID-19 mRNA vaccination in patients with rheumatoid arthritis, psoriatic arthritis and spondyloarthritis: a national cohort study
Warren Fong, Ting Hui Woon, Li‐Ching Chew, et al.
Advances in Rheumatology (2023) Vol. 63, Iss. 1
Open Access | Times Cited: 7
Vaccination against SARS-CoV-2 in rheumatic diseases: Safety issues
Б. С. Белов, А. М. Лила, Е. Л. Насонов
Rheumatology Science and Practice (2022) Vol. 60, Iss. 1, pp. 21-31
Open Access | Times Cited: 11
Attitudes toward COVID-19 Vaccination: A Survey of Chinese Patients with Rheumatic Diseases
Zixi Yi, Zhongqiang Yao, Dan Xu, et al.
Vaccines (2022) Vol. 10, Iss. 10, pp. 1604-1604
Open Access | Times Cited: 9
A Case Report and Literature Review of a Triple-Vaccinated, Rituximab-Treated Systemic Lupus Erythematosus patient with COVID-19 pneumonia
Christos Michailides, Themistoklis Paraskevas, Maria Lagadinou, et al.
ARP Rheumatology (2024) Vol. 3, Iss. 2, pp. 145-150
Open Access | Times Cited: 1
Association of PCSK9 inhibitors with mortality: insights from a retrospective cohort analysis
Chi‐Hsien Huang, Shiow‐Ing Wang, Frank S. Fan, et al.
European Heart Journal - Cardiovascular Pharmacotherapy (2024) Vol. 10, Iss. 6, pp. 505-514
Closed Access | Times Cited: 1
COVID-19 from a rheumatology perspective: bibliometric and altmetric analysis
Bohdana Doskaliuk, Roman Yatsyshyn, І. П. Кліщ, et al.
Rheumatology International (2021) Vol. 41, Iss. 12, pp. 2091-2103
Open Access | Times Cited: 11
Corticosteroids and disease‐modifying antirheumatic drugs for coronavirus disease 2019 in patients with rheumatoid arthritis
Yuhan Chen, Yuan‐Ti Lee, Kevin Sheng‐Kai
International Journal of Rheumatic Diseases (2023) Vol. 26, Iss. 7, pp. 1391-1392
Closed Access | Times Cited: 3
Severe COVID pneumonia and undetectable B cells after vaccination in patients previously treated with rituximab: a case series
Takashi Sakano, Edward A. Bittner, Marvin G. Chang
Postgraduate Medicine (2022) Vol. 134, Iss. 2, pp. 239-243
Closed Access | Times Cited: 4
A vaccination update for rheumatologists—SARS‐CoV‐2, influenza and herpes zoster
Peter K. K. Wong, Manjari Lahiri, David Chien Lye, et al.
International Journal of Rheumatic Diseases (2021) Vol. 24, Iss. 8, pp. 979-983
Open Access | Times Cited: 5
Rituximab‐to‐vaccine interval on SARS‐CoV‐2 immunogenicity in children: The potential role of prior natural infection
Renato Gualtieri, Sabine Yerly, Stéphanie Garcia-Tarodo, et al.
Pediatric Allergy and Immunology (2024) Vol. 35, Iss. 5
Open Access
Consensus for risk management in the prescription of biologic therapies or targeted synthetic antirheumatic drugs: Colombian Association of Rheumatology 2023
Elías Gonzalo Forero Illera, Andrés Ricardo Fernández Aldana, Daniel G. Fernández‐Ávila, et al.
Revista Colombiana de Reumatología (English Edition) (2024)
Closed Access
Consenso para la gestión de riesgo en la prescripción de terapias biológicas o de antirreumáticos sintéticos con blanco dirigido: Asociación Colombiana de Reumatología 2023
Elías Gonzalo Forero Illera, Andrés Ricardo Fernández Aldana, Daniel G. Fernández‐Ávila, et al.
Revista Colombiana de Reumatología (2024)
Closed Access
Recommendations for COVID vaccination for dermatological patients on immunosuppressive/immunomodulatory therapy (IADVL Academy)
Deepika Pandhi, Malathi Munisamy, BhabaniS. T. P. Singh
Indian Dermatology Online Journal (2021) Vol. 12, Iss. 7, pp. 4-4
Open Access | Times Cited: 4
Recommendations for enhanced primary series (third dose) COVID-19 vaccination for people with rheumatic diseases: Chapter of Rheumatologists, College of Physicians, Singapore
Chuanhui Xu, Manjari Lahiri, Amelia Santosa, et al.
Singapore Medical Journal (2023)
Open Access | Times Cited: 1
Bibliometric analysis of scientific papers on adverse reactions to COVID-19 vaccines published between 2019 and 2023
Xuan Yang, Mingcong Chen, Lin Cao, et al.
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 3
Open Access | Times Cited: 1
Questionnaire Survey on Vaccination Willingness and the Status of COVID-19 Vaccination Among Patients with Rheumatic Disease: A Single-Center Survey in China
Feng Wang
Patient Preference and Adherence (2022) Vol. Volume 16, pp. 2067-2076
Open Access | Times Cited: 2
Immunogenicity of Vaccines Against SARS-CoV-2 In Patients With Rheumatic Diseases
BS Belov, N. V. Muravyevа, A. N. Kulikov
Antibiot Khimioter = Antibiotics and Chemotherapy (2022) Vol. 67, Iss. 5-6, pp. 70-80
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top